These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 28927692)

  • 1. Prognostic Influence of Tumor Stroma on Breast Cancer Subtypes.
    Cid S; Eiro N; Fernández B; Sánchez R; Andicoechea A; Fernández-Muñiz PI; González LO; Vizoso FJ
    Clin Breast Cancer; 2018 Feb; 18(1):e123-e133. PubMed ID: 28927692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-derived matrix metalloproteinase-13 (MMP-13) correlates with poor prognoses of invasive breast cancer.
    Zhang B; Cao X; Liu Y; Cao W; Zhang F; Zhang S; Li H; Ning L; Fu L; Niu Y; Niu R; Sun B; Hao X
    BMC Cancer; 2008 Mar; 8():83. PubMed ID: 18373849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor grade and matrix metalloproteinase 2 expression in stromal fibroblasts help to stratify the high-risk group of patients with early breast cancer identified on the basis of st Gallen recommendations.
    Niemiec J; Adamczyk A; Małecki K; Ambicka A; Ryś J
    Clin Breast Cancer; 2013 Apr; 13(2):119-28. PubMed ID: 23375518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of MMP-9 and TIMP-1 serum and tissue expression in breast cancer.
    Wu ZS; Wu Q; Yang JH; Wang HQ; Ding XD; Yang F; Xu XC
    Int J Cancer; 2008 May; 122(9):2050-6. PubMed ID: 18172859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Relationship between the expression of matrix metalloproteinase-13 protein and other biomarkers, prognosis in invasive breast cancer].
    Zhang B; Liu YX; Cao WF; Cao XC; Ning LS; Hao XS
    Zhonghua Bing Li Xue Za Zhi; 2008 Jul; 37(7):471-6. PubMed ID: 19035119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumoral and stromal expression of MMP-2, MMP-9, MMP-14, TIMP-1, TIMP-2, and VEGF-A in cervical cancer patient survival: a competing risk analysis.
    Azevedo Martins JM; Rabelo-Santos SH; do Amaral Westin MC; Zeferino LC
    BMC Cancer; 2020 Jul; 20(1):660. PubMed ID: 32669083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of E-cadherin, beta-catenin, cathepsin D, gelatinases and their inhibitors in invasive ductal breast carcinomas.
    Zhang YG; DU J; Tian XX; Zhong YF; Fang WG
    Chin Med J (Engl); 2007 Sep; 120(18):1597-605. PubMed ID: 17908479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of ru'ai shuhou recipe on the matrix metalloproteinases and the inhibitive factors in the recurrence and metastasis of HER2 positive breast cancer].
    Wu XQ; Shao SJ; Qu WC
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Nov; 32(11):1526-30. PubMed ID: 23359979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of ER, PR and HER-2/neu (C-erb B 2) reactivity pattern with histologic grade, tumor size and lymph node status in breast cancer.
    Azizun-Nisa ; Bhurgri Y; Raza F; Kayani N
    Asian Pac J Cancer Prev; 2008; 9(4):553-6. PubMed ID: 19256737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical Expression Of Matrix Metalloproteinase-1 (MMP-1) in Different Types Of Breast Carcinoma And Its Comparison With ER/PER and HER2/neu.
    Shamsi FB; Anwar A; Lail RA; Bukhari MH; Naseem N; Nagi AH
    J Ayub Med Coll Abbottabad; 2022; 34(1):12-16. PubMed ID: 35466619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ductal invasive mammary carcinoma--clinicopathological prognostic factors related to immunohistochemical expression of hormonal receptors and Her2/neu oncoprotein.
    Recăreanu F; Simionescu C; Georgescu CV; Pirici E
    Rom J Morphol Embryol; 2011; 52(3 Suppl):1059-64. PubMed ID: 22119825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic and prognostic relevance of MMP-11 expression in the stromal fibroblast-like cells adjacent to invasive ductal carcinoma of the breast.
    Min KW; Kim DH; Do SI; Pyo JS; Kim K; Chae SW; Sohn JH; Oh YH; Kim HJ; Choi SH; Choi YJ; Park CH
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S433-42. PubMed ID: 23115007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MMP1 and MMP11 Expression in Peripheral Blood Mononuclear Cells upon Their Interaction with Breast Cancer Cells and Fibroblasts.
    Eiro N; Cid S; Aguado N; Fraile M; de Pablo N; Fernández B; Domínguez F; González LO; Vizoso FJ
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-Derived Matrix Metalloproteinase-13 (MMP-13) Expression in Benign and Malignant Breast Lesions.
    Ameli F; Ghafourina Nassab F; Masir N; Kahtib F
    Asian Pac J Cancer Prev; 2021 Aug; 22(8):2603-2609. PubMed ID: 34452576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloproteinase-2 (MMP-2) and MMP-9 expression in invasive ductal carcinoma of the breast.
    Sullu Y; Demirag GG; Yildirim A; Karagoz F; Kandemir B
    Pathol Res Pract; 2011 Dec; 207(12):747-53. PubMed ID: 22030137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FOXA1 expression in breast cancer--correlation with luminal subtype A and survival.
    Badve S; Turbin D; Thorat MA; Morimiya A; Nielsen TO; Perou CM; Dunn S; Huntsman DG; Nakshatri H
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4415-21. PubMed ID: 17671124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical study of matrix metalloproteinase 9 and tissue inhibitor of matrix metalloproteinase 1 in benign and malignant breast tissue--strong expression in intraductal carcinomas of the breast.
    Rahko E; Kauppila S; Pääkkö P; Blanco G; Apaja-Sarkkinen M; Talvensaari-Mattila A; Turpeenniemi-Hujanen T; Jukkola A
    Tumour Biol; 2009; 30(5-6):257-64. PubMed ID: 19887890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of matrix metalloproteinase-1, -9, -13, and tissue inhibitor of metalloproteinases-1 in basal cell carcinomas of the eyelid.
    Zlatarova ZI; Softova EB; Dokova KG; Messmer EM
    Graefes Arch Clin Exp Ophthalmol; 2012 Mar; 250(3):425-31. PubMed ID: 21881840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression and clinical significance of MMP-2, MMP-9,TIMP-1, and TIMP-2 in breast carcinoma].
    Fan SQ; Wei QY; Li MR; Zhang LQ; Liang QC
    Ai Zheng; 2003 Sep; 22(9):968-73. PubMed ID: 12969531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of matrix metalloproteinase-2, -9, tissue inhibitor-1 of matrix metalloproteinase and CD44 variant 6 in head and neck cancer metastasis.
    Xu YP; Zhao XQ; Sommer K; Moubayed P
    J Zhejiang Univ Sci; 2003; 4(4):491-501. PubMed ID: 12861629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.